Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir Prophylaxis in Burn Patients
NCT02349828Phase 3Withdrawn
- Sponsor
- Southern Illinois University
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of aciclovir in herpes simplex (HSV), sponsored by Southern Illinois University. Planned start Sep 2015; status: withdrawn.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT02349828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349828.